XML 16 R6.htm IDEA: XBRL DOCUMENT v3.22.0.1
Condensed Statements of Cash Flows (Unaudited) - USD ($)
 3 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Operating activities    
Net loss $ (2,807,475) $ (1,959,480)
Adjustments to reconcile net loss to net cash used in operating activities:    
Amortization and depreciation 25,161 18,736
Stock-based compensation 203,072 245,829
Issuance costs attributed to financing activities   3,053
Revaluation of convertible notes   (1,974)
Non-cash lease expense 26,235 13,848
Change in assets and liabilities:    
Accounts receivable 23,708 (71,474)
Inventory (130,828) (13,816)
Prepaid and other assets 13,649 (7,253)
Accounts payable 291,172 (243,017)
Accrued expenses, deferred revenue, operating leases and other liabilities (323,830) 111,316
Net cash used in operating activities (2,679,136) (1,904,232)
Investing activities    
Purchase of fixed assets (61,491)  
Net cash used in investing activities (61,491)  
Financing activities    
Issuance costs related to convertible notes   (3,053)
Proceeds from issuance of common stock in connection with common stock offering 13,350,582
Proceeds from advance related to future financing   5,000,000
Issuance costs related to common stock offering (1,326,978)  
Net cash provided by financing activities 12,023,604 4,996,947
Net increase in cash 9,282,977 3,092,715
Cash at beginning of period 6,901,346 4,036,397
Cash at end of period 16,184,323 7,129,112
Supplemental non-cash financing and investing transactions:    
Conversion of convertible notes into equity   1,005,232
Unpaid issuance costs attributed to convertible notes and common stock offering 322 $ 50,400
Reclass of deferred offering costs to additional paid-in capital in connection with common stock offering $ 24,980